Compare Unichem Lab with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ORCHID PHARMA LTD UNICHEM LAB/
ORCHID PHARMA LTD
 
P/E (TTM) x 62.8 -0.5 - View Chart
P/BV x 0.7 0.1 572.8% View Chart
Dividend Yield % 2.1 0.0 -  

Financials

 UNICHEM LAB   ORCHID PHARMA LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ORCHID PHARMA LTD
Sep-13
UNICHEM LAB/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs292194 150.5%   
Low Rs18235 520.0%   
Sales per share (Unadj.) Rs167.7276.5 60.6%  
Earnings per share (Unadj.) Rs-3.6-79.2 4.6%  
Cash flow per share (Unadj.) Rs5.9-43.5 -13.7%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.353.9 690.2%  
Shares outstanding (eoy) m70.3870.45 99.9%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.40.4 341.3%   
Avg P/E ratio x-65.3-1.4 4,515.7%  
P/CF ratio (eoy) x39.9-2.6 -1,513.7%  
Price / Book Value ratio x0.62.1 30.0%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6808,067 206.8%   
No. of employees `0002.62.8 92.9%   
Total wages/salary Rs m2,3932,527 94.7%   
Avg. sales/employee Rs Th4,535.26,956.1 65.2%   
Avg. wages/employee Rs Th919.8902.5 101.9%   
Avg. net profit/employee Rs Th-98.2-1,993.0 4.9%   
INCOME DATA
Net Sales Rs m11,80119,477 60.6%  
Other income Rs m984407 241.7%   
Total revenues Rs m12,78519,884 64.3%   
Gross profit Rs m-8351,103 -75.7%  
Depreciation Rs m6742,519 26.7%   
Interest Rs m755,227 1.4%   
Profit before tax Rs m-600-6,236 9.6%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-343-125 274.3%   
Profit after tax Rs m-256-5,580 4.6%  
Gross profit margin %-7.15.7 -125.0%  
Effective tax rate %57.32.0 2,852.8%   
Net profit margin %-2.2-28.7 7.6%  
BALANCE SHEET DATA
Current assets Rs m20,38411,014 185.1%   
Current liabilities Rs m5,02932,060 15.7%   
Net working cap to sales %130.1-108.1 -120.4%  
Current ratio x4.10.3 1,179.8%  
Inventory Days Days10595 110.4%  
Debtors Days Days13534 401.9%  
Net fixed assets Rs m9,02329,440 30.7%   
Share capital Rs m141705 20.0%   
"Free" reserves Rs m26,0582,043 1,275.7%   
Net worth Rs m26,1993,800 689.5%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m31,49646,510 67.7%  
Interest coverage x-7.0-0.2 3,611.6%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.40.4 89.5%   
Return on assets %-0.6-0.8 75.3%  
Return on equity %-1.0-146.9 0.7%  
Return on capital %-2.0-3.7 53.5%  
Exports to sales %69.437.9 183.2%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs m8,1887,378 111.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m8,1887,513 109.0%   
Fx outflow Rs m5965,649 10.6%   
Net fx Rs m7,5921,865 407.2%   
CASH FLOW
From Operations Rs m-3,2781,682 -194.9%  
From Investments Rs m-2,860-9,860 29.0%  
From Financial Activity Rs m-246,644 -0.4%  
Net Cashflow Rs m-4,690-1,535 305.6%  

Share Holding

Indian Promoters % 50.1 32.3 155.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 4.6 328.3%  
FIIs % 3.0 3.3 90.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 31.7 55.3 57.3%  
Shareholders   20,176 84,811 23.8%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   WYETH LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 20, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS